Current Edition

BioNTech

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

Homegrown mRNA players BioNTech and CureVac have signed on to supply Germany with vaccines against future health emergencies for years to come. Germany will pay …

Continue Reading →